Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Goldberg

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancerR M Goldberg, A K Hatfield, M Kahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancyH C Pitot, R M Goldberg, J M Reid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trialsJ Taieb, F A Sinicrope, L Pederson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2020
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT databaseM E Salem, J Yin, R M Goldberg, et al.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
Journal of the National Cancer Institute|August 5, 1999
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancersK C Halling, A J French, S K McDonnell, et al.
Journal of the National Cancer Institute|September 10, 2021
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer TrialsJun Yin, Mohamed E Salem, Jesse G Dixon, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancerR M Goldberg, A K Hatfield, M Kahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancyH C Pitot, R M Goldberg, J M Reid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trialsJ Taieb, F A Sinicrope, L Pederson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2020
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT databaseM E Salem, J Yin, R M Goldberg, et al.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
Journal of the National Cancer Institute|August 5, 1999
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancersK C Halling, A J French, S K McDonnell, et al.
Journal of the National Cancer Institute|September 10, 2021
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer TrialsJun Yin, Mohamed E Salem, Jesse G Dixon, et al.
Pageof 9